Somnigroup (SGI) Q2 2025 earnings review
Mattress Firm Synergies Drive Guidance Raise, But Core Profitability Declines
Somnigroup reported a 53% surge in Q2 revenue to $1.88 billion, a headline number driven entirely by the Mattress Firm acquisition. However, the bottom line told a different story, with adjusted EPS falling 16% YoY to $0.53 due to higher interest expense, increased share count, and significant advertising investments for the new Sealy product launch. On a like-for-like basis, the company continues to outperform a weak US bedding market, with sales down only low-single-digits versus an estimated high-single-digit market decline. Encouragingly, management raised its full-year EPS guidance, signaling strong confidence that cost and sales synergies from the Mattress Firm integration are materializing faster than initially planned.
🐂 Bull Case
Management signaled that Mattress Firm integration benefits are arriving faster than expected. The share of Tempur Sealy brands at Mattress Firm is now targeted at low 50% for 2025, driving an incremental $20 million in EBITDA benefit versus prior expectations.
On a like-for-like basis, Somnigroup's sales declined only 1-2% in North America, substantially outperforming the broader US bedding market, which is estimated to be down high-single-digits.
The international segment remains a powerful growth engine, posting its ninth consecutive quarter of meaningful constant currency sales expansion with 10% growth in Q2.
🐻 Bear Case
Adjusted EPS fell 16% YoY. The decline was driven by acquisition-related financing costs and a 240 basis point drop in like-for-like operating margin in the core North American segment, reflecting heavy investment and cost pressures.
The underlying US bedding market remains in a downturn. The company's guidance continues to assume the industry will be down mid-single digits for the full year, providing a challenging backdrop for growth.
Post-acquisition leverage remains elevated at 3.6x, above the company's 2-3x target range. This constrains capital returns, with share repurchases expected to be minimal until deleveraging is achieved in 2026.
⚖️ Verdict: ⚪
Mixed. The raised guidance and accelerating synergy capture are clear positives, demonstrating strong execution on the Mattress Firm integration. However, the 16% YoY decline in adjusted EPS cannot be ignored. It highlights significant near-term headwinds from integration costs and a weak US market. The bull case hinges on a smooth path to synergy realization, while the bear case is validated by the current pressure on profitability.
Key Themes
Synergies from Mattress Firm Arriving Ahead of Schedule
The primary driver behind the upgraded guidance is the accelerated realization of synergies. Management now expects Tempur Sealy brands to represent a low 50% share of Mattress Firm's sales in 2025, up from a high 40% initial target. This balance of share shift is expected to contribute a $40 million EBITDA benefit in 2025, which is $20 million more than previously anticipated. The company also remains on track for at least $100 million in annual run-rate cost synergies by 2027.
Profit Erosion Contradicts 'Solid Quarter' Narrative
Despite management's positive tone, the 16% YoY drop in adjusted EPS from $0.63 to $0.53 is a significant red flag. This was caused by a combination of higher interest expense (up $39M), a 19% increase in diluted shares outstanding from the acquisition, and a 240 basis point compression in the core North American like-for-like adjusted operating margin. This highlights that the quality of earnings is currently poor, even as top-line numbers are inflated by M&A.
Sealy Relaunch Aims to Reignite Growth
The company is making a major investment in its all-new Sealy Posturepedic collection, dubbed the 'largest bedding launch in industry history.' While the associated advertising spend is currently pressuring North American margins, the company is seeing strong early momentum. The launch is designed to capture share in the critical mid-entry-level segment and is supported by a new national advertising campaign that has more than doubled Sealy's share of voice in the market.
International Business Remains a Powerful Growth Engine
The Tempur Sealy International segment continues its impressive run, delivering 10% constant currency sales growth. This marks the ninth consecutive quarter of meaningful expansion. The strength, driven by new product launches and expanded distribution, provides crucial diversification and a reliable offset to the softness in the US market.
Underlying US Bedding Market Remains Weak
Management estimates the North American bedding market declined by high single digits in the quarter. While Somnigroup is successfully gaining share, operating in a contracting market creates persistent headwinds. The company's full-year guidance continues to assume the US market will decline by mid-single digits, signaling no expectation of a near-term recovery.
Strategic Investment in Sleep Technology
The company announced a $25 million equity investment for a 15.6% stake in Fullpower, the company behind the Sleeptracker-AI technology used in Tempur-Ergo Smart Bases. The deal includes a multiyear extension of its exclusive rights to the technology through 2036. This move deepens its commitment to the high-growth smart bed category and reinforces its position as an innovator in sleep technology.
Other KPIs
Stripping out the impact of acquisitions and divestitures reveals the company's true underlying performance. Mattress Firm sales declined 1%, and Tempur Sealy North America sales were down 2% (adjusted for a distribution loss). Both figures represent significant outperformance against an industry estimated to be down high-single-digits. International sales grew a robust 10% on a constant currency basis.
Consolidated net leverage ended the quarter at 3.6x, slightly up from 3.5x in Q1 and above the company's 2x to 3x target range. Management is focused on paying down debt, expecting leverage to fall to approximately 3.35x by year-end and return to the target range in 2026. Until then, share repurchases will be minimal.
Guidance
Stable. Management raised guidance from a prior midpoint of $2.475 to a new midpoint of $2.55. While an increase, this revised guidance only brings the full-year expectation back in line with the $2.55 actually achieved in FY24. The raise is primarily driven by pulling forward synergies, not an improvement in the underlying market. This implies a return to YoY EPS growth in the second half of the year.
The updated guidance contemplates a sales midpoint of approximately $7.4 billion. This is based on a continued expectation for the US bedding industry to be down mid-single digits, with Somnigroup's various segments outperforming that trend on a like-for-like basis.